Amylx Pharmaceuticals Inc vs SpaceX — how do they compare? Amylx Pharmaceuticals Inc trades at $23.66 (market cap $2.64B), while SpaceX trades at $137.86 (market cap $1.76T). The key difference: SpaceX is far larger — about 666.7× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.
| AMLX | SPCX | |
|---|---|---|
Market Cap | $2.64B | $1.76T |
Sector | Health | Technology |
52-Week High | $24.19 | $202.09 |
52-Week Low | $7.82 | $108.27 |
Enterprise Value | $2.39B | $1.70T |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →